A recent clinical trial of Zetia, a cholesterol lowering drug prescribed by physicians to about 1 million people a week, failed to show that the drug has any medical benefits. The results will add to the growing concern over Zetia and Vytorin, a drug that combines Zetia with another cholesterol medicine in a single pill. About 60 percent of patients who take Zetia do so in the form of Vytorin, which combines Zetia with the cholesterol drug Zocor. While Zetia lowers cholesterol in 15 percent to 20 percent in most patients, no trial has ever shown that it can reduce heart attacks and strokes – or even that it reduces the growth of the fatty plaques in arteries that can cause heart problems.
To read the entire New York Times article, please click on the following link:
http://www.nytimes.com/2008/01/14/business/14cnd-drug.html?_r=2&hp&oref=slogin&oref=slogin
For more information on defending medical malpractice, nursing home and general liability matters in Florida contact Howard Citron at Citron & Associates, P.A. – www.citronlegal.com.
